%0 Journal Article %T First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013 %+ Institut de Veille Sanitaire (INVS) %+ Antenne Régionale de Lutte contre les Infections Nosocomiales [Lille] (ARLIN) %+ Génétique Moléculaire des Virus à ARN - Molecular Genetics of RNA Viruses (GMV-ARN (UMR_3569 / U-Pasteur_2)) %+ Centre National de Référence des virus influenzae (Grippe) (CNR) %+ Virologie et pathogenèse virale (VPV) %+ Cellule d'Intervention Biologique d'Urgence - Laboratory for Urgent Response to Biological Threats (CIBU) %+ Université de Lille %+ Service maladies infectieuses [CH Douai] %+ CH Valenciennes %+ Cellule d'Intervention Biologique d'Urgence (Centre National de Référence) - Laboratory for Urgent Response to Biological Threats (National Reference Center) (CIBU) %+ Virologie et pathologie humaine (VirPath) %A Mailles, A %A Blanckaert, K %A Chaud, P %A van der Werf, S %A Lina, B %A Caro, V %A Campese, C %A Guéry, B %A Prouvost, H %A Lemaire, X %A Paty, M %A Haeghebaert, S %A Antoine, D %A Ettahar, N %A Noel, H %A Behillil, S %A Hendricx, S %A Manuguerra, Jean-Claude %A Enouf, V %A La Ruche, G %A Semaille, C %A Coignard, B %A Lévy-Bruhl, D %A Weber, F %A Saura, C %A Che, D %A The Investigation Team, Collective %< avec comité de lecture %@ 1560-7917 %J Eurosurveillance %I European Centre for Disease Prevention and Control %V 18 %N 24 %P 20502 %8 2013-06-13 %D 2013 %R 10.2807/ese.18.24.20502-en %M 23787161 %Z Life Sciences [q-bio]Journal articles %X In May 2013, Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection was diagnosed in an adult male in France with severe respiratory illness, who had travelled to the United Arab Emirates before symptom onset. Contact tracing identified a secondary case in a patient hospitalised in the same hospital room. No other cases of MERS-CoV infection were identified among the index case’s 123 contacts, nor among 39 contacts of the secondary case, during the 10-day follow-up period. %G English %Z Investigation team : InVS, Saint Maurice, France: Sandrine Barquin, Fatima Belghiti, Alexandre Blake, Gabriel Bedubourg, Isabelle Bonmarin, Jérémie Carré, Carole Debreyer, Gilles Delmas, Anne Gallay, Claire Gourier-Fréry, Etienne Lucas, Roselyne Pinget, Mathieu Tourdjmann, Sarah Tubiana, Dieter Van Cauteren, Annie Velter, Manuel Zubaran. InVS, Lille, France: Audrey Andrieu, Emile Baro, Guillaume Clement. National Reference Center for influenza viruses, Hospices Civils de Lyon and Virpath, Université Claude Bernard Lyon1, Lyon, France: Maude Bouscambert, Martine Valette. Centre Hospitalier Régional et Universitaire, Université de Lille 2, Lille, France: Karine Faure, Hugues Melliez, Fanny Vuotto. Centre hospitalier, Douai, France: Loubna El-Mansouf. Centre hospitalier, Valenciennes, France: Anne-Adélaide Cracco. 5www.eurosurveillance.org Regional Health Agency, Lille, France: Jean-Philippe Legendre, Sandrine Segovia-Kueny. Centre hospitalier universitaire, Tourcoing, France: Eric Senneville. %2 https://pasteur.hal.science/pasteur-03915090/document %2 https://pasteur.hal.science/pasteur-03915090/file/art20502-en.pdf %L pasteur-03915090 %U https://pasteur.hal.science/pasteur-03915090 %~ PASTEUR %~ UNIV-PARIS7 %~ CNRS %~ UNIV-LYON1 %~ INVS %~ UNIV-LILLE %~ UDL %~ UNIV-LYON %~ UNIV-PARIS %~ UP-SCIENCES %~ PASTEUR_UMR3569 %~ GMV-ARN